Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Phosphorus 32 in Treating Patients With Glioblastoma Multiforme [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating phosphorus-32 for treating glioblastoma and currently lists an unknown statu…
-
CLINICAL_TRIALS trial_result · 2013-08-22Clinical Trial Update: AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
This is a Phase 2 trial update reporting on cediranib (AZD2171) in adults with recurrent glioblastoma multiforme and related brain tumors; t…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 3]
This Phase 3 trial evaluating radiation therapy plus chemotherapy for supratentorial glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme [Phase 2]
Phase 2 study evaluating bevacizumab (Avastin) in combination with temozolomide and irinotecan for unresectable, multifocal glioblastoma mul…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating the combination of erlotinib and temozolomide with radiation therapy in adults with glioblastoma and rel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-26Clinical Trial Update: Ph II Bevacizumab + Etoposide for Pts w Recurrent MG [Phase 2]
Phase II study evaluating bevacizumab plus etoposide in patients with recurrent malignant glioma (glioblastoma and gliosarcoma) completed; r…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma [Phase 1]
A Phase I study evaluating vorinostat in combination with bevacizumab and irinotecan for recurrent glioblastoma. The trial status is complet…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating NBI-3001 followed by surgery in patients with recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating gefitinib for newly diagnosed glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluating vorinostat for progressive or recurrent glioblastoma multiforme has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of vorinostat and bortezomib in adults with progressive or recurrent glioblastoma multiforme; the…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas [Phase 1]
A Phase 1 trial evaluating motexafin gadolinium with MRI-guided surgery for high-grade gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: ADV-TK Improves Outcome of Recurrent High-Grade Glioma [Phase 2]
Phase 2 trial of ADV-TK in recurrent high-grade glioma reports improved outcomes in malignant glioma and glioblastoma. The study is complete…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Sunitinib to Treat Recurrent Brain Cancer [Phase 2]
A Phase 2 trial of sunitinib for recurrent brain cancer (glioblastoma, malignant glioma, and anaplastic glioma) was terminated with results …
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM [Phase 2]
Phase 2 trial evaluating sorafenib plus protracted temozolomide in recurrent glioblastoma completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating vorinostat (SAHA) with bevacizumab and daily temozolomide for recurrent malignant gliomas, including g…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma [NA]
A completed clinical trial update describing a pharmacologic study of methotrexate in patients with recurrent high-grade glioma undergoing s…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating temozolomide in adults with newly diagnosed primary malignant glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Ph. I Temozolomide + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Phase 1]
A Phase I study of temozolomide combined with O6-benzylguanine and irinotecan in patients with recurrent or progressive cerebral anaplastic …
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating motexafin gadolinium with radiation therapy for newly diagnosed glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-18Clinical Trial Update: Evaluation of FLT PET and MRI as Imaging Biomarkers of Early Treatment Response in Patients With Glioblastoma
This clinical trial evaluated FLT PET and MRI imaging biomarkers to assess early treatment response in glioblastoma; the study status is com…
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma [Phase 2]
A Phase 2 clinical trial evaluating ritonavir and lopinavir for progressive or recurrent high-grade glioma was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
This document reports the completion of a Phase 1 trial evaluating radiation therapy with gadolinium texaphyrin for supratentorial glioblast…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Curcumin Bioavailability in Glioblastoma Patients
A completed clinical trial evaluated the bioavailability of curcumin in patients with glioblastoma undergoing surgery.
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma [Phase 3]
Phase 3 trial of bevacizumab with temozolomide and radiotherapy in newly diagnosed glioblastoma completed; results posted in 2013.